Deutsche Bank Cuts HCA Healthcare Price Target to $476 From $540, Maintains Buy Rating
Deutsche Bank has reduced its price target for HCA Healthcare (HCA) to $476 from $540, while reaffirming a Buy rating on the stock. This adjustment indicates a revised valuation despite the continued positive outlook from the bank regarding HCA Healthcare's prospects.